NEW YORK, Sept. 5 (GenomeWeb News) - Intradigm announced today that it had developed siRNA capable of achieving 90 percent inhibition of the SARS virus in cell-based studies.
Already have a GenomeWeb or 360Dx account?Login Now.
Researchers have treated an X-linked genetic disease affecting three babies in utero, Stat News reports.
The Associated Press reports that the US Centers for Disease Control and Prevention is beefing up sequencing as a tool to investigate foodborne illnesses.
Researchers have sequenced samples from ancient toilets to study past eating habits and health, NPR reports.
In Nature this week: ash dieback disease fungal genome, and more.